| UHC Commercial Medical & Drug | Cochlear Implants - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Cognitive Rehabilitation and Coma Stimulation - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Collagen Crosslinks and Biochemical Markers of Bone Turnover - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Complement Inhibitors - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Cosmetic and Reconstructive Procedures - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Denosumab - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Diagnostic Dynamic Spinal Visualization and Vertebral Motion Analysis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Discogenic Pain Treatment - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Elective Inpatient Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |